Lidocaine Modulates Cytokine Production and Reprograms the Tumor Immune Microenvironment to Enhance Anti-Tumor Immune Responses in Gastric Cancer
Open Access
- 31 March 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (7) , 3236
Abstract
Lidocaine, a local anesthetic, has been shown to modulate immune responses. This study examines its effects on cytokine production in peripheral blood mononuclear cells (PBMCs) from healthy donors and tumor-infiltrating immune cells (TIICs) from gastric cancer patients. PBMCs from healthy donors and TIICs from gastric cancer patients were treated with lidocaine. Cytokine production was assessed using flow cytometry and cytokine assays, with a focus on IFN-γ, IL-12, IL-10, TGF-β, and IL-35 levels. Cytotoxicity against primary gastric cancer cells (PGCCs) was also evaluated. Lidocaine inhibited IFN-γ production in CD8+ PBMCs and IL-12 in CD14+ PBMCs while increasing anti-inflammatory cytokines (IL-10, TGF-β, IL-35) in CD4+CD25+ and CD14+ cells. In TIICs, lidocaine enhanced IFN-γ and IL-12 production in CD8+ and CD14+ cells while reducing IL-10, TGF-β, and IL-35 levels, promoting an M1-like phenotype in macrophages. Mechanistically, lidocaine enhanced IFN-γ production in sorted CD8+ TIICs through G-protein-coupled receptor (GPCR) signaling and increased IL-12 production in sorted CD14+ TIICs via the toll-like receptor 4 (TLR4) signaling pathway. Lidocaine also increased IFN-γ production and cytotoxicity in CD8+ TIICs via NF-κB activation. Importantly, lidocaine did not affect the viability of PBMCs, TIICs, or PGCCs at concentrations up to 1.5 mM. Lidocaine reprogrammed the tumor immune microenvironment, enhancing anti-tumor immune responses, suggesting its potential to modulate immune functions in gastric cancer.Keywords
All Related Versions
Funding Information
- Ditmanson Medical Foundation of Chia-Yi Christian Hospital (R111-03, 110S0023A, 111S0023A, 112S0023A, 113S0023A, 114S0023A, TCVGH-NCHU 1127605, TCVGH-NCHU-1137607, TCVGH-NCHU-114-OA017, 112-2313-B-005-050-MY3)
- iEGG and Animal Biotechnology Center from The Feature Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (R111-03, 110S0023A, 111S0023A, 112S0023A, 113S0023A, 114S0023A, TCVGH-NCHU 1127605, TCVGH-NCHU-1137607, TCVGH-NCHU-114-OA017, 112-2313-B-005-050-MY3)
- Taichung Veterans General Hospital (R111-03, 110S0023A, 111S0023A, 112S0023A, 113S0023A, 114S0023A, TCVGH-NCHU 1127605, TCVGH-NCHU-1137607, TCVGH-NCHU-114-OA017, 112-2313-B-005-050-MY3)
- Ministry of Science and Technology, Taiwan (R111-03, 110S0023A, 111S0023A, 112S0023A, 113S0023A, 114S0023A, TCVGH-NCHU 1127605, TCVGH-NCHU-1137607, TCVGH-NCHU-114-OA017, 112-2313-B-005-050-MY3)
This publication has 74 references indexed in Scilit:
- High baseline tumor burden‐associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2‐STAT3‐PD‐L1 pathwayCancer Communications, 2023
- The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodesCell, 2022
- Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasisInternational Immunopharmacology, 2022
- Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responsesImmunity, 2022
- Pharmacological validation of targets regulating CD14 during macrophage differentiationEBioMedicine, 2020
- Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint BlockadeCell, 2017
- Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinomaExperimental Cell Research, 2015
- Induced regulatory T cells: mechanisms of conversion and suppressive potentialHuman Immunology, 2012
- Anti-cytokine therapeutics and infectionsVaccine, 2003
- A method for estabilishing primary cultures of human gastric epithelial cellsMethods in Cell Science, 2000